News and Trends 15 May 2023New menopause drug gets FDA approval The U.S. Food and Drug Administration has approved Astellas Pharma's Veozah (fezolinetant), an oral medication for the treatment of moderate… May 15, 2023 - 2 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 14 Mar 2023Astellas menopause study meets endpoints but leukemia drug disappoints There was good and bad news this week from Japanese company Astellas Pharma Inc. as one of its trials yielded… March 14, 2023 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 30 Sep 2022Treatment for hot flushes and night sweats accepted for regulatory review by EMA A treatment for moderate to severe vasomotor symptoms (VMS) has been accepted by the European Medicines Agency (EMA) for regulatory… September 30, 2022 - 2 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 5 Sep 2022Astellas ‘encouraged’ by menopause symptom treatment results in China Astellas Pharma Inc. has announced topline results from its phase 3 MOONLIGHT 3 clinical trial in women in mainland China… September 5, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
More News! 24 Jun 2022Gurnet Point Capital and Patient Square Capital buy Radius Health for $890M Global pharmaceutical company, Radius Health Inc, announced this week (June 23) that it has entered into a definitive agreement to… June 24, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email